A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood
Clinical trial NCT04445090 · TERMINATED
Trial details
- NCT number
- NCT04445090
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-21
- Primary completion
- 2021-09-10
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.